
Courses
Advance your knowledge in engaging, interactive courses developed and taught by leaders in the field.
Course Types
Browse All MDS Courses
New courses are added regularly.
Sign up for email notifications »
Train the Trainer Program for Speech and Language Therapists - Trainer Application
In-PersonEurope
Salerno, Italy
Sep 17, 2026 - Sep 18, 2026
Foundational / Beginner
1087 <p>The MDS-ES Train the Trainer Program for Speech and Language Therapists seeks to support the training of speech and language therapists to identify common movement disorders and advise on appropriate next steps in the diagnosis, management, and care of patients with movement disorders. The MDS Train the Trainer Program (TTP) will take place June - October 2026 using the Train the Trainer education model, wherein MDS provides centralized curriculum, resources, training and support to regionally identified trainers, who in turn utilize these materials to prepare and implement training programs for allied health professionals in their local languages and organizations.<br /></p> Ataxias, Chorea/Huntingtons Disease (HD), Corticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD), Drug-induced Movement Disorders/Tardive dyskinesia, Dystonia, Freezing of Gait (FOG), Functional Movement Disorders, Gait & Balance Disorders, Genetic & Hereditary Disorders, Hyperkinetic Movement Disorders, Lewy-body dementia (LBD), Movement Disorders Emergencies, Multiple Systems Atrophy (MSA), Myoclonus, Non-motor Symptoms/Disorders, Other Movement Disorders, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP), Rare/Uncommon Movement Disorders, Restless Legs Syndrome (RLS)/Periodic Limb Movement Disorder (PLMD), Speech Disorders, Speech Therapy, Stiff Person syndrome (SPS), Therapies-Other, Tics/Tourettes syndrome (TS), Tremor/Essential Tremor (ET) 870 0.00 https://education.movementdisorders.org/Detail/1087/MDS-ES-Train-the-Trainer-Program-for-Speech-and-Language-Therapists---Trainer-Application https://education.movementdisorders.org/Upload/ActivityImages/26ESTTP_202x10892189.png https://education.movementdisorders.org/Upload/BannerImages/26ESTTP_734x404318891.jpg 2026-09-17T00:00:00 2026-09-18T00:00:00 Salerno <p><br></p><p><br></p> MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26ESTTP In-Person Training Schedule_no faculty_16032026115934.pdf" rel="noopener noreferrer" target="_blank"><img width="87" height="87" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1747846457039_21052025115416.png" class="fr-fic fr-dii"></a><!--[endif]--><strong>Course Schedule</strong><strong> </strong><!--[if !vml]--><!--[endif]--><strong> </strong><!--[if !vml]--><img width="98" height="98" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1747846457070_21052025115417.png" class="fr-fic fr-dii"><!--[endif]--><strong>Course Faculty</strong></p><p><br></p><p><strong><em><span style="color: rgb(184, 49, 47);">Application</span></em></strong><span style="color: rgb(184, 49, 47);"> <em><strong>Deadline:</strong></em></span><em><span style="color: rgb(184, 49, 47);"><strong> </strong>April 30, 2026</span></em></p><p><br></p><p><strong>TRAIN THE TRAINER FOR SPEECH AND LANGUAGE THERAPISTS: BACKGROUND</strong></p><p>The MDS Train the Trainer Program (TTP) will occur beginning in mid-2026 and ending in mid-2027 using the Train the Trainer education model, wherein MDS provides centralized curriculum, resources, training and support to regionally identified trainers, who in turn utilize these materials to prepare and implement training programs for allied health professionals in their local languages and organizations.<br><br><strong>PROGRAM OVERVIEW</strong><br>The MDS-ES Train the Trainer Pilot Program occurs from June 2026 – July 2027.<br><br><strong><span style="color: rgb(184, 49, 47);">Accepted Trainers must complete all components of the MDS-ES Train the Trainer Program outlined below.</span></strong><br><br></p><ul><li><strong>Online Education: June – September 2026</strong><br>Participate in online lectures and discussion. Additional information on dates and format will be shared during the orientation call.<br><em>Supplemental online modules will be provided to attendees. It is expected that all attendees planning to apply for the in-person Train the Trainer Program</em><span style="box-sizing: border-box; margin: 0px; padding: 0px;"><em><strong><span style="color:rgb(184, 49, 47);"> </span></strong></em></span><span style="color: rgb(0, 0, 0);"><em>for Speech and Language Therapists complete these online modules.</em></span><br><br></li><li><strong>In-Person Workshop: September 17-18, 2025 – Salerno, Italy</strong><br>Required in-person workshop scheduled for September 17-18, 2026 in Salerno, Italy. MDS will provide travel support for Trainers to participate in person.<br><em>IMPORTANT: In-person participation at the Workshop is <strong><u>mandatory</u></strong> for acceptance in the program. If you cannot attend the Workshop, please do not apply for the program.</em><br><br></li><li><strong>Discussion of Local Training Plans: September – October 2026</strong><br>Trainers will present and discuss their Local Training Implementation Plans with a faculty mentor prior to implementation.<br><br></li><li><strong>Implementation of Local Training Program: November 2026 – July 2027</strong><br>Trainers prepare and implement the local training programs in their home institutions or other appropriate setting. Trainers must complete the training and required event reporting before the end of July 2027.</li></ul><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>1. Describe the specific communication and swallowing needs of patients with Movement Disorders</p><p>2. Indicate and discuss the most appropriate assessment tools -clinical and instrumental- to use for communication and swallowing problems of patients with Movement Disorders</p><p>3. Integrate information and propose a treatment plan based on evidence and Movement Disorders-specific clinical needs</p><p>4. Evaluate and revise the management of communication and swallowing </p><p>5. Plan and present a local training program to transfer learning to colleagues</p><p><br><strong>INTENDED AUDIENCE</strong></p><p>The MDS-ES Train the Trainer Program is intended for speech and language therapists residing within the MDS-European Section.<br><br><em>Eligible applicants must:</em></p><ul><li>Be a credentialed allied health professional with a current affiliation at a hospital, clinic, or medical school</li><li>Be a current MDS Member residing and practicing within the MDS-European Section</li><li>Have the ability to host training for allied health professionals in local institution. (Local training can be presented in English or local language.)</li><li>Provide verification of permission from Institution/Department Director to participate in MDS-ES Train the Trainer Program (June 2026 – October 2026), including in person attendance at the Training Workshop (September 17-18, 2026, Salerno, Italy)</li><li>Provide verification of ability and permission to coordinate and implement a local training session at home institution or appropriate national society event (November 2026 – July 2027)</li></ul> Salerno 0 /Courses/Train-the-Trainer-Program-for-Speech-and-Language-Therapists---Trainer-Application.htm Train the Trainer Program for Speech and Language Therapists - Trainer Application 2026-03-16T15:01:21.190 0 0 Foundational / Beginner Health Professional-Speech English Europe In-Person Italy
School for Young Neurologists
In-PersonEurope
London, United Kingdom, UK
Jul 16, 2026 - Jul 18, 2026
Foundational / Beginner
1086 <p>The MDS-ES School for Young Neurologist is designed for young neurologists and early-career movement disorder specialists who wish to deepen their expertise in the field of movement disorders, with particular focus on clinical examination, diagnosis and treatment. The program offers a comprehensive overview of main movement disorders and of recent developments on genetics, digital health and treatment with device aided therapies. Teaching will be delivered by internationally known experts from specialized movement disorder centre.<strong></strong><strong></strong></p> Biomarkers, Biomarkers & Diagnostic Tools, Botulinum toxin, Clinical Trials, Deep brain stimulation, Dopaminergic medications, Focused Ultrasound, Gene Therapies, Genetics, Infusion therapy, Medications for motor complications, Medications for motor symptoms, Medications for non-motor symptoms, Neuroimaging, Neuropathology, Rating Scales, Therapies-Pharmacological, Therapies-Surgical 1260 0.00 https://education.movementdisorders.org/Detail/1086/MDS-ES-School-for-Young-Neurologists https://education.movementdisorders.org/Upload/ActivityImages/26ESSYN_202x108554660.png https://education.movementdisorders.org/Upload/BannerImages/26ESSYN_734x404520523.jpg 2026-07-16T00:00:00 2026-07-18T00:00:00 London, United Kingdom <p><br></p><p><br></p> MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Course%20Agenda%20MDS%20ES%20SYN%20London%20NO%20Faculty_11032026080456.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Course schedule_23012024043738.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Course%20Agenda%20MDS%20ES%20SYN%20London%20NO%20Faculty_11032026080456.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Schedule</strong><strong> </strong></a><strong> </strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing_11032026085243.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing_11032026085243.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a></p><p><br></p><p><em>Schedule as of March 11, 2026 </em><br><strong><em><span style="color: rgb(175, 38, 38);">Course Application</span><span style="color: rgb(184, 49, 47);"> Deadline: </span></em></strong><em><span style="color: rgb(184, 49, 47);">April </span></em><em><span style="color: rgb(184, 49, 47);">1, 2026</span></em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong> $250 USD<br><strong>Non-Members*:</strong> $325 USD</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf">Click here to view the MDS Regional Course Cancellation Policy & Visa Assistance Information</a></p><p><br><strong>SCHEDULE OVERVIEW</strong><br>Day 1: Thursday, July 16, 2026 from 8:00 - 19:00<br>Day 2: Friday, July 17, 2026 from 8:30 - 21:30</p><p>Day 3: Saturday, July 18, 2026 from 8:00 - 13:00<br><br><span style="background-color: null;"><strong>COURSE VENUE</strong></span></p><p>St George’s University Hospital, </p><p>Blackshaw Road, SW17 0QT</p><p>London, United Kingdom</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. To perform a structured and comprehensive clinical evaluation of patients presenting with movement disorders.<br>2. To present and analyze movement disorder case histories using a structured and evidence-based approach.<br>3. To deliver accurate diagnoses in patients with common and straightforward movement disorder presentations.<br>4. To formulate and critically appraise differential diagnoses in patients with complex or atypical movement disorder presentations.<br>5. To develop, evaluate, and appropriately modify individualized management plans in accordance with current evidence and best clinical practice.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is designed for young neurologists and early-career movement disorder specialists who wish to deepen their expertise in the field of movement disorders</p> London, United Kingdom 0 /Courses/School-for-Young-Neurologists3.htm School for Young Neurologists 2026-03-11T12:01:06.837 0 0 Foundational / Beginner Clinician Fellow-Clinical Fellow-Movement Disorders Resident-Neurology Europe In-Person UK
MDS Parkinson's Disease Educational Course for Industry Professionals
In-Person
Phoenix, USA
May 23, 2026
Foundational / Beginner, Experienced / Intermediate
1082 <p>As the premier medical society in the world that focuses on movement disorders, MDS is uniquely positioned to provide a program that will help industry professionals better understand Parkinson’s disease and give them the ability to work in a more informed manner. The primary purpose of this program is to provide industry professionals with a basic knowledge of Parkinson's disease from a diagnostic and therapeutic perspective, empowering them to better understand the challenges of this disorder and its treatment.</p><p> </p><p style="text-align:center;"><strong>This program will take place on May 23, 2026 in Phoenix, AZ, USA ahead of the World Parkinson’s Congress.</strong></p> 480 0.00 https://education.movementdisorders.org/Detail/1082/MDS-Parkinson's-Disease-Educational-Course-for-Industry-Professionals https://education.movementdisorders.org/Upload/ActivityImages/Copenhagen-course-LMS-image360304.png 2026-05-23T00:00:00 2026-05-23T00:00:00 Phoenix, Arizona MDS Development <p><!--[if !vml]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Agenda_24022026022907.pdf" rel="noopener noreferrer" target="_blank"><img width="87" height="87" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1771959920669_24022026010519.png" class="fr-fic fr-dii"></a><!--[endif]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Agenda_24022026022907.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Schedule</strong></a><strong> </strong><!--[if !vml]--><!--[endif]--><strong> </strong><!--[if !vml]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing_24022026023005.pdf" rel="noopener noreferrer" target="_blank"><img width="98" height="98" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1771959920715_24022026010519.png" class="fr-fic fr-dii"></a><!--[endif]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing_24022026023005.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong> $800 USD<br><strong>Non-Members:</strong> $800 USD</p><p>*<em>Companies sending three or more participants and served as sponsors of the 2025 International Congress of Parkinson’s Disease and Movement Disorders in Honolulu, HI are eligible for a 15% discount on registration fees.</em></p><p><br></p><p><strong>COURSE VENUE</strong></p><p>Phoenix, AZ, United States</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Recognize the differential diagnosis of Parkinson’s disease</p><p>2. Discuss the clinical features of Parkinson’s disease from early to advanced stages</p><p>3. Identify the benefits, limitations and complications of currently available treatments for PD including pharmacotherapy and surgery</p><p>4. Discuss non-motor features of Parkinson’s disease</p><p>5. Identify outcome measures, unmet needs, emerging therapies, and biomarkers for Parkinson’s disease</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for industry professionals who work for pharmaceutical and medical device companies.</p> Phoenix 0 /Courses/MDS-Parkinsons-Disease-Educational-Course-for-Industry-Professionals1.htm MDS Parkinson's Disease Educational Course for Industry Professionals 2026-02-27T15:01:10.407 0 0 Foundational / Beginner Experienced / Intermediate Industry In-Person USA
Journal CME 41.02: Polyelectromyography Under Propofol to Differentiate Functional from Idiopathic Dystonia: A Pilot Study
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
1076 <p>The Journal CME 41.02 article aims to investigate potential differences in muscle activity between ID and FD patients using polyelectromyography (PEMG) under anesthesia.</p> Biomarkers, Biomarkers & Diagnostic Tools, Dystonia, Functional Movement Disorders, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Other Movement Disorders, Rating Scales Roberto Eleopra, MD 60 1.00 https://education.movementdisorders.org/Detail/1076/Journal-CME-41-02:-Polyelectromyography-Under-Propofol-to-Differentiate-Functional-from-Idiopathic-Dystonia:-A-Pilot-Study https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-02-19T00:00:00 2027-02-19T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.02%20-%20Disclosures_16022026081618.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the diagnostic overlap between functional and idiopathic dystonia and the need for objective biomarkers</p><p>2. Evaluate the role of sedation-based PEMG findings in differentiating FD from ID</p><p>3. Assess the clinical utility and limitations of EMG patterns under anesthesia in the diagnostic workup of dystonia</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.02-Polyelectromyography-Under-Propofol-to-Differentiate-Functional-from-Idiopathic-Dystonia-A-Pilot-Study.htm Journal CME 41.02: Polyelectromyography Under Propofol to Differentiate Functional from Idiopathic Dystonia: A Pilot Study Journal CME 41.02 2026-02-19T09:01:11.360 0 0 Experienced / Intermediate Clinician Fellow Industry Researcher Resident Journal CME CME English On-Demand USA
Genetic Counseling in Parkinson's Disease
On Demand
60 Minutes
Foundational / Beginner
1050 Genetics has become an important clinical tool and can also identify people at risk for disease. This is an introductory module on genetic counseling and testing for Parkinson’s disease and includes some of the most important aspects to consider. Biomarkers & Diagnostic Tools, Genetics, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD) Deborah Raymond, MS, CGC, Maya Rawal, MS, CGC, Rachel Saunders Pullman, MD, MPH , MS 60 1.00 https://education.movementdisorders.org/Detail/1050/Genetic-Counseling-in-Parkinson's-Disease https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-45-001-Genetic-Counseling-202x108969975.jpg 2026-02-16T00:00:00 2029-02-16T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Disclosures - Genetic Counseling in Parkinson's Disease _17122025113848.pdf" rel="noopener noreferrer" target="_blank">HERE.</a> All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Deborah Raymond, MS, CGC - Mount Sinai Beth Israel Medical, New York, NY, United States</p><p>Maya Rawal, MS, CGC - Mount Sinai Beth Israel Medical, New York, NY, United States</p><p>Rachel Saunders-Pullman, MD, MPH, MS - Mount Sinai Beth Israel Medical, New York, NY, United States</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Understand the principal components of genetic counseling for Parkinson’s disease</p><p>2. Understand the most common genetic contributors to Parkinson’s disease </p><p>3. Understand genetic testing types</p><p>4. Understand the meaning of test results and how genetic variants are interpreted</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Genetic-Counseling-in-Parkinsons-Disease.htm Genetic Counseling in Parkinson's Disease 2026-02-16T15:01:04.617 0 0 Foundational / Beginner Clinician Health Professional Resident Student CME On-Demand USA
Journal CME 41.01: Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
1074 <p>The Journal CME 41.01 article aims to investigate cross-sectional and longitudinal associations between baseline cerebrospinal fluid (CSF) PENK concentration and regional brain atrophy, compared identified patterns with CSF neurofilament light (NfL), and evaluated PENK and NfL for discriminating between HD Integrated Staging System (HD-ISS) stage 0 versus 1 in a far-from-onset HD gene-expanded (HDGE) cohort.</p> Biomarkers, Biomarkers & Diagnostic Tools, Chorea/Huntingtons Disease (HD), Hyperkinetic Movement Disorders Mena Farag, MBBS, MRCP 60 1.00 https://education.movementdisorders.org/Detail/1074/Journal-CME-41-01:-Cerebrospinal-Fluid-Proenkephalin-Predicts-Striatal-Atrophy-Decades-before-Clinical-Motor-Diagnosis-in-Huntington's-Disease https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-02-11T00:00:00 2027-02-11T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.01%20-%20Disclosures_06022026033938.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the biological rationale for CSF proenkephalin as a striatum-specific biomarker in Huntington’s disease<br>2. Assess associations between baseline CSF PENK and longitudinal regional brain atrophy compared with neurofilament light<br>3. Evaluate the role of CSF PENK in distinguishing early HD-ISS stages and its potential value for clinical trial enrichment<br><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.01-Cerebrospinal-Fluid-Proenkephalin-Predicts-Striatal-Atrophy-Decades-before-Clinical-Motor-Diagnosis-in-Huntingtons-Disease.htm Journal CME 41.01: Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease Journal CME 41.01 2026-02-11T12:01:11.930 0 0 Experienced / Intermediate Clinician Fellow Industry Researcher Resident Journal CME CME English On-Demand USA
Tremor from Basic Science to Clinical Diagnosis and Therapy
In-PersonEurope
Salerno, Italy
Sep 18, 2026 - Sep 19, 2026
Experienced / Intermediate
1073 During the <em>MDS-ES Tremor from Basic Science to Clinical Diagnosis and Therapy</em> course, evidence based results and speakers’ experiences will be reviewed from the basic science and clinical points of view and will incorporate talks about newer perspective on tremor measurement with digital/AI assisted tools. Moreover, therapeutic options will be reviewed in depth, from pharmacological treatments to surgical procedures (including DBS and MRgFUS) to alternative options. Two interactive video-case sessions will be included to precipitate further discussion. Basic/Translational Neuroscience, Biomarkers, Biomarkers & Diagnostic Tools, Botulinum toxin, Clinical Trials, Deep brain stimulation, Dopaminergic medications, Etiology & Pathophysiology, Focused Ultrasound, Gene Therapies, Genetics, Hyperkinetic Movement Disorders, Infusion therapy, Medications for motor complications, Medications for motor symptoms, Medications for non-motor symptoms, Neuroimaging, Neuropathology, Rating Scales, Therapies-Pharmacological, Therapies-Surgical, Tremor/Essential Tremor (ET) 750 0.00 https://education.movementdisorders.org/Detail/1073/MDS-ES-Tremor-from-Basic-Science-to-Clinical-Diagnosis-and-Therapy https://education.movementdisorders.org/Upload/ActivityImages/26ESBASIC_202x108890630.png https://education.movementdisorders.org/Upload/BannerImages/26ESBASIC_734x404532438.jpeg 2026-09-18T00:00:00 2026-09-19T00:00:00 Salerno <p><br></p><p><br></p> MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26ESBASIC Course Schedule_02032026011833.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Course schedule_23012024043738.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><strong>Course Schedule</strong><strong> </strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty Listing_LMS_02032026011858.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><strong>Course Faculty</strong></p><p><br></p><p><em>Schedule as of March 1, 2026 </em></p><p><strong><em><span style="color: rgb(184, 49, 47);">Application Deadline:</span> </em></strong><em> July 1, 2026</em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong> $275 USD<br><strong>Members</strong><strong>: Junior / HP / Basic Science / No Fee:</strong> $250 USD<br><strong>Non-Members*:</strong> $325 USD</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em><br><br></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf" rel="noopener noreferrer" target="_blank">Click here to view the MDS Regional Course Cancellation Policy & Visa Assistance Information</a></p><p><br></p><p><strong>SCHEDULE OVERVIEW</strong><br>Day 1: Friday, September 18, 2026 from 13:00 - 20:00<br>Day 2: Saturday, September 19, 2026 from 9:00 - 16:30<br><br><strong>COURSE VENUE</strong></p><p>Fondazione EBRIS, Salerno, Italy</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Demonstrate how to assess tremor during patient examination</p><p>2. Associate and interpret outcomes from different sources of tremor assessment (clinical scales, electrophysiology, digital tools) </p><p>3. Plan treatment strategies for tremor syndromes (including pharmacological and surgical options) </p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for neurologists, neurosurgeons, neuroscientists and general practitioners interested in tremor.</p> Salerno 0 /Courses/Tremor-from-Basic-Science-to-Clinical-Diagnosis-and-Therapy.htm Tremor from Basic Science to Clinical Diagnosis and Therapy 2026-02-09T12:01:07.030 0 0 Experienced / Intermediate Clinician Clinician-Movement Disorder Specialist Fellow-Movement Disorders Researcher-Clinical Resident-Neurology English Europe In-Person Italy
School for Young Neurologists
In-PersonAfrica
Cairo Governorate, Egypt
May 01, 2026 - May 02, 2026
Foundational / Beginner
1068 <p>The MDS-African Section School for Young Neurologists is an opportunity for young neurologists who are interested in specializing in Movement Disorders to receive in-depth instruction from internationally recognized Movement Disorders experts. Students will attend lectures and panel discussions with question-and-answer sessions, will have the opportunity to examine patients with movement disorders, and engage in a differential diagnosis with the international experts.</p><p> </p><p style="text-align:center;"><strong>APPLICATION/BURSARY DEADLINE:</strong> February 20, 2026</p> Biomarkers, Biomarkers & Diagnostic Tools, Botulinum toxin, Clinical Trials, Deep brain stimulation, Dopaminergic medications, Focused Ultrasound, Gene Therapies, Genetics, Infusion therapy, Medications for motor complications, Medications for motor symptoms, Medications for non-motor symptoms, Neuroimaging, Neuropathology, Rating Scales, Therapies-Pharmacological, Therapies-Surgical 1320 0.00 https://education.movementdisorders.org/Detail/1068/MDS-AS-School-for-Young-Neurologists https://education.movementdisorders.org/Upload/ActivityImages/26AFRSYN_202x108244151.png 2026-05-01T00:00:00 2026-05-02T00:00:00 Hilton Cairo Heliopolis, Cairo Governorate MDS Education <p><strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/LMS Prelim Agenda - 26AFRSYN School for Young Neurologists_09022026103407.pdf" rel="noopener noreferrer" target="_blank"><img src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Course schedule_13052025105320.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a></strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/LMS Prelim Agenda - 26AFRSYN School for Young Neurologists_09022026103407.pdf" rel="noopener noreferrer" target="_blank"> <strong>Course Schedule</strong></a><strong> </strong> <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26AFRSYN Faculty Listing - NO FACULTY_09022026104631.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26AFRSYN Faculty Listing - NO FACULTY_09022026104631.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a></p><p><br></p><p><em>Schedule as of January 27, 2026</em></p><p><strong><em><span style="color: rgb(175, 38, 38);">Application/Travel Bursary Deadline:</span> February 20, 2026</em></strong></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong> $25 USD<br><strong>Non-Members*:</strong> $150 USD</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf">Click here to view the MDS Regional Course Cancellation Policy & Visa Assistance Information</a></p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><ol><li>Recognize the clinical characteristics of different types of movement disorders in both adults and children.</li><li>Perform a comprehensive assessment, including history taking and neurological examination, of patients with movement disorders.</li><li>Identify the various etiologies underlying different types of movement disorders.</li><li>Recognize best practices in the management of movement disorders, including advanced therapies.</li><li>Develop a structured approach to the use of botulinum toxin for the treatment of dystonia and other movement disorders.</li><li>Recognize challenges in the management of patients with movement disorders in Africa and tailor treatment strategies to individual patient needs.</li></ol><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>The MDS-AS School for Young Neurologists is intended for young neurologists within five years of their completion of general neurological training who are interested in specializing in movement disorders, and young neurologists who are already training in movement disorders.</p> Cairo Governorate 0 /Courses/School-for-Young-Neurologists2.htm School for Young Neurologists 2026-02-05T15:01:06.970 0 0 Foundational / Beginner Clinician-General Neurologist Clinician-Movement Disorder Specialist Fellow-Clinical Fellow-Movement Disorders Resident-Neurology Africa In-Person Egypt
11th Annual Movement Disorders School for Neurology Residents
In-PersonPan America
Boston, USA
Sep 12, 2026 - Sep 13, 2026
Foundational / Beginner
1066 <p>Led by internationally recognized movement disorder experts, the International Parkinson and Movement Disorder Society's Pan American Section (MDS-PAS) 11th Annual Movement Disorders School for Neurology Residents offers a broad education on movement disorders, the latest research and potential career paths in the field. The goal of the course is to provide in-depth education on movement disorders and encourage neurology residents to consider specializing in the field.<br /><strong></strong><strong></strong><strong></strong></p> Ataxias, Biomarkers, Biomarkers & Diagnostic Tools, Chorea/Huntingtons Disease (HD), Corticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD), Drug-induced Movement Disorders/Tardive dyskinesia, Dystonia, Freezing of Gait (FOG), Functional Movement Disorders, Gait & Balance Disorders, Genetic & Hereditary Disorders, Genetics, Hyperkinetic Movement Disorders, Lewy-body dementia (LBD), Movement Disorders Emergencies, Multiple Systems Atrophy (MSA), Myoclonus, Neuroimaging, Neuropathology, Other Movement Disorders, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP), Rare/Uncommon Movement Disorders, Rating Scales, Restless Legs Syndrome (RLS)/Periodic Limb Movement Disorder (PLMD), Stiff Person syndrome (SPS), Tics/Tourettes syndrome (TS), Tremor/Essential Tremor (ET) 840 0.00 https://education.movementdisorders.org/Detail/1066/MDS-PAS-11th-Annual-Movement-Disorders-School-for-Neurology-Residents https://education.movementdisorders.org/Upload/ActivityImages/24PASSNR_202x108212056.png https://education.movementdisorders.org/Upload/BannerImages/26PASSNR_734x404275597.jpeg 2026-09-12T00:00:00 2026-09-13T00:00:00 Renaissance Boston Seaport District, Boston, Massachusetts <p><br></p><p><br></p> <p>This program is made possible with support from the The Michael J. Fox Foundation for Parkinson’s Research.</p><p><img src="https://education.movementdisorders.org/Upload/SupportImages/21SNR-mjff-logo530882.jpg" alt="" class="fr-fic fr-dii"></p><p>And their generous giving partners:<br><br><img data-fr-image-pasted="true" src="https://education.movementdisorders.org/Upload/SponsorImages/21SNR-Edmond-J.-Safra-Foundation-Logo694865.png" alt="" class="fr-fic fr-dii"><br><br></p><p><em>While our generous sponsors make our educational offering possible, their support does not influence content, perspective, or panelist selections.</em></p> MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26PASSNR Course Schedule_05032026022302.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Course schedule_23012024043738.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><strong>Course Schedule</strong><strong> </strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty Listing_LMS_24022026122848.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><strong>Course Faculty</strong></p><p><br></p><p><em>Schedule as of March 5, 2026 </em><br><br><strong><em><span style="color: rgb(175, 38, 38);">Course Application</span><span style="color: rgb(184, 49, 47);"> Deadline: </span></em></strong><em><span style="color: rgb(184, 49, 47);">July </span></em><em><span style="color: rgb(184, 49, 47);">1, 2026</span></em></p><p><br><strong>SCHEDULE OVERVIEW</strong><br>Day 1: Saturday, September 12, 2026 from 8:00 - 20:00<br>Day 2: Sunday, September 13, 2026 from 8:00 - 13:00<br><br><span style="background-color: null;"><strong>COURSE VENUE</strong></span></p><p>Renaissance Boston Seaport District<br>606 Congress Street, Boston, MA, 02210 </p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p><span style="color:#000000;">1. Examine a patient with a movement disorder</span></p><p><span style="color:#000000;">2. Reach a diagnosis on straightforward movement disorders cases</span></p><p><span style="color:#000000;">3. Propose a differential diagnosis on more complex movement disorders patients</span></p><p><span style="color:#000000;">4. Present a movement disorders case history</span></p><p><span style="color:#000000;">5. Design, review and modify a patient treatment plan</span></p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for <span style="color:#1f1f1f;">General neurology residents (f</span>irst-year interns, second-year and third-year) who are undecided in a sub-specialty and would like to learn about movement disorders.<br><br><strong>PARTICIPANT VIDEO CASE COMPETITION</strong></p><p>Selected participants are strongly encouraged to submit an interesting case for consideration to be presented at the Video Case Competition. The goal of this session is for participants to learn how experts approach challenging cases. The winner will be awarded free registration to the next PAS Regional Congress or MDS International Congress.</p> Boston 0 /Courses/11th-Annual-Movement-Disorders-School-for-Neurology-Residents.htm 11th Annual Movement Disorders School for Neurology Residents 2026-02-03T12:01:09.140 0 0 Foundational / Beginner Resident Resident-Neurology Resident-Other English Pan America In-Person USA
School for Device Aided Therapies in Parkinson’s Disease
In-PersonAsia / Oceania
Bangkok, Thailand
May 06, 2026 - May 07, 2026
Experienced / Intermediate
1070 <p>The <em>MDS-AOS School for Device Aided Therapies in Parkinson’s Disease</em> aims to cultivate the next generation of experts in DBS and infusion therapy for PD, providing them with a comprehensive overview, case-based discussion and hands-on workshop in DBS and infusion therapy in PD. This year's school will start with the basics and then discuss recent updates of DBS and infusion therapy in PD.<br /><br /><span style="color:#990000;"><strong>REGISTRATION DEADLINE: April 22, 2026</strong></span><strong></strong><strong></strong></p> Clinical Trials, Deep brain stimulation, Focused Ultrasound, Gene Therapies, Infusion therapy, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Surgical 690 0.00 https://education.movementdisorders.org/Detail/1070/MDS-AOS-School-for-Device-Aided-Therapies-in-Parkinson’s-Disease https://education.movementdisorders.org/Upload/ActivityImages/26AOSNMOD_202x108589130.png 2026-05-06T00:00:00 2026-05-07T00:00:00 King Chulalongkorn Memorial Hospital, Bangkok <p><br></p><p><br></p> MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26AOSNMOD Course Schedule_03032026102610.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Course schedule_23012024043738.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><strong>Course Schedule</strong><strong> </strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty Listing_LMS_02032026012240.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><strong>Course Faculty</strong></p><p><br></p><p><em>Schedule as of March 1, 2026</em><br><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members: </strong>$200 USD<br><strong>Junior & No-Fee Members: </strong>$150 USD<br><strong>Non-Members: </strong>$200 USD</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf">Click here to view the MDS Regional Course Cancellation Policy & Visa Assistance Information</a></p><p><br></p><p><span style="background-color: null;"><strong>COURSE VENUE</strong></span></p><p>King Chulalongkorn Memorial Hospital</p><p>Bangkok, Thailand<br><br></p><p><strong>SCHEDULE OVERVIEW<em> </em></strong></p><p>Day 1: Wednesday, May 6, 2026 | 8:15 - 17:10<br>Day 2: Thursday, May 7, 2026 | 8:30 - 17:20</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Develop the multi-disciplinary team for deep brain stimulation and infusion therapy</p><p>2. Classify the candidates of deep brain stimulation and infusion therapy</p><p>3. Compare the various targets for deep brain stimulation and choose the best target for subjects</p><p>4. Act initial programming and troubleshooting in patients with deep brain stimulation and those with infusion therapy</p><p>5. Act with deep brain stimulation programmer and infusion pump during hands-on workshops</p><p>6. Establish a local and international network of young clinicians and researchers, fostering collaborations and facilitating future research in the field of deep brain stimulation</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>The target audience is clinicians, movement disorder specialists, fellows, neurology residents, clinical researchers, and clinical nurse specialists.<br><br></p> Bangkok 0 /Courses/School-for-Deep-Brain-Stimulation-and-Infusion-Therapy-in-Parkinsons-Disease.htm School for Device Aided Therapies in Parkinson’s Disease 2026-01-29T12:01:06.523 0 0 Experienced / Intermediate Clinician Clinician-Movement Disorder Specialist Fellow Fellow-Clinical Fellow-Movement Disorders Health Professional-Clinical Nurse Specialist Researcher-Clinical Resident-Neurology English Asia / Oceania In-Person Thailand
Many MDS courses are free or offer need-based assistance. MDS members receive reduced rates.
View each couse's details for rates and available grant opportunities.
Popular Courses

A Comprehensive Review of Movement Disorders for the Clinical Practitioner
"As a rite of passage, every movement disorder fellow must pass through the Aspen course."
“The Aspen Course” has been the foundation for movement disorders education for more than 30 years, providing a broad but in-depth overview of the field's core concepts. Learn from and network alongside the foremost leaders in the field.

School for Young Neurologists
A prestigious opportunity to learn from the foremost experts and gain the knowledge, practical skills, and connections that can shape your career.
Offered annually in each region.





















